Name: Exer
Brand: Exer

01Competitive Landscape

Where Exer appears to differentiate (observed in public materials)

Vendor materials emphasize RTM code enablement and report billing metrics; these are presented as commercial differentiation but should be independently validated.
Camera-based, sensor-free motion measurement is the primary technical differentiator highlighted in vendor materials.
The vendor asserts that video is not stored in the cloud and that processing occurs on-device, which is a privacy-oriented claim in public materials.

Where alternatives may be stronger

Employer/plan-focused vendors may offer broader program operations, clinician networks, and publicly available scale metrics that align with employer or payer procurement models.
Vendors that provide device-based biofeedback may offer a different measurement fidelity profile relevant to certain clinical workflows.

Market share / adoption trends (observed evidence)

This research pass did not identify strong public adoption metrics for Exer. LinkedIn and public materials indicate a small team and describe use across multiple specialties. By contrast, some competitors publish broader scale metrics in press materials.

	Exer (exer.ai)	Sword Health	Kaia Health
Starting Price	Not publicly listed (demo-based). Patient app is free when prescribed.	Public materials describe outcome-based pricing approaches and reference program pricing narratives.	Employer/plan oriented; pricing and coverage depend on benefits and contracts.
Primary Buyer Type	Provider organizations seeking sensor-free motion measurement and remote monitoring.	Employers and health plans seeking MSK programs with clinician networks and device-supported feedback.	Employers and health plans seeking computer-vision–assisted MSK therapy programs.
Key Strength	Camera-based motion analysis without dedicated wearables; vendor emphasizes privacy-oriented handling of video.	Emphasis on outcome-based pricing and device-supported biofeedback.	Published work and press materials describe computer-vision exercise correction research.
Key Weakness	Limited public presence on major B2B review platforms; iOS-only patient app; limited public documentation of enterprise security certifications.	Device requirements and program scale may not align with all buyer needs.	Program availability and measurement focus may vary depending on deployment model.

01Competitive Landscape

Where Exer appears to differentiate (observed in public materials)

Vendor materials emphasize RTM code enablement and report billing metrics; these are presented as commercial differentiation but should be independently validated.
Camera-based, sensor-free motion measurement is the primary technical differentiator highlighted in vendor materials.
The vendor asserts that video is not stored in the cloud and that processing occurs on-device, which is a privacy-oriented claim in public materials.

Where alternatives may be stronger

Employer/plan-focused vendors may offer broader program operations, clinician networks, and publicly available scale metrics that align with employer or payer procurement models.
Vendors that provide device-based biofeedback may offer a different measurement fidelity profile relevant to certain clinical workflows.

Market share / adoption trends (observed evidence)

	Exer (exer.ai)	Sword Health	Kaia Health
Starting Price	Not publicly listed (demo-based). Patient app is free when prescribed.	Public materials describe outcome-based pricing approaches and reference program pricing narratives.	Employer/plan oriented; pricing and coverage depend on benefits and contracts.
Primary Buyer Type	Provider organizations seeking sensor-free motion measurement and remote monitoring.	Employers and health plans seeking MSK programs with clinician networks and device-supported feedback.	Employers and health plans seeking computer-vision–assisted MSK therapy programs.
Key Strength	Camera-based motion analysis without dedicated wearables; vendor emphasizes privacy-oriented handling of video.	Emphasis on outcome-based pricing and device-supported biofeedback.	Published work and press materials describe computer-vision exercise correction research.
Key Weakness	Limited public presence on major B2B review platforms; iOS-only patient app; limited public documentation of enterprise security certifications.	Device requirements and program scale may not align with all buyer needs.	Program availability and measurement focus may vary depending on deployment model.

Exer

01Competitive Landscape

Where Exer appears to differentiate (observed in public materials)

Where alternatives may be stronger

Market share / adoption trends (observed evidence)

02Market Map

01Competitive Landscape

Where Exer appears to differentiate (observed in public materials)

Where alternatives may be stronger

Market share / adoption trends (observed evidence)

02Market Map